AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33245323 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 7571
Study 33245323 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vigorous physical activity)
Number of subjects: 7571
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 associated mucormycosis (CAM) group
Number of subjects: 52
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes mellitus
Number of subjects: 52
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 52
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroid pulse therapy
Number of subjects: 52
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM group
Number of subjects: 52
Study 36202942 — intervention group
Group type: EXPERIMENTAL
Intervention: Expired patients in CAM group
Number of subjects: 52
Study 32656738 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognition and Interaction Training for Autism (SCIT‐A)
Number of subjects: 41
Study 32656738 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 41
Study 32651286 — intervention group
Group type: EXPERIMENTAL
Intervention: Laquinimod 0.6 mg
Number of subjects: 374
Study 32651286 — intervention group
Group type: EXPERIMENTAL
Intervention: Laquinimod 1.5 mg
Number of subjects: 374
Study 32651286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 35491679 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg oral dose
Number of subjects: 0
Study 35491679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32819873 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with non-calcified plaques (NCPs)
Number of subjects: 45
Study 32819873 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with high-risk plaques (HRPs)
Number of subjects: 45
Study 32819873 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of HRPs
Number of subjects: 45
Study 34734780 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive taping
Number of subjects: 28
Study 34734780 — intervention group
Group type: COMPARATOR
Intervention: Tissue adhesive
Number of subjects: 28
Study 33600580 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual biofeedback
Number of subjects: 19
Study 33600580 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory biofeedback
Number of subjects: 19
Study 32504575 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention including enhanced HIV testing, earlier antiretroviral therapy (ART), and strengthened male circumcision services
Number of subjects: 2625
Study 32504575 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 2625
Study 32504575 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention
Number of subjects: 2625
Study 35932269 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy
Number of subjects: 45
Study 33884609 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 mcg/kg/h) in PRD group
Number of subjects: 40
Study 33884609 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (SS) in PR group
Number of subjects: 40
Study 33884609 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 mcg/kg/h) in substudy 2
Number of subjects: 40
Study 33884609 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (SS) in substudy 2
Number of subjects: 40
Study 32739974 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir at a dose of 8g/day
Number of subjects: 2
Study 32739974 — intervention group
Group type: COMPARATOR
Intervention: CMV hyperimmune globulin (HIG)
Number of subjects: 2
Study 36624180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (6 mg once a day)
Number of subjects: 106
Study 36624180 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (16 mg twice a day)
Number of subjects: 106
Study 36624180 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone (50 mg thrice a day)
Number of subjects: 106
Study 34788432 — intervention group
Group type: EXPERIMENTAL
Intervention: PVAC Gold group
Number of subjects: 75
Study 34788432 — intervention group
Group type: COMPARATOR
Intervention: ST‐CF
Number of subjects: 75
Study 32036290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostering Connections program (group-based experiential intervention) delivered over 6 weeks
Number of subjects: 79
Study 32036290 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 79
Study 32036290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostering Connections program
Number of subjects: 79
Study 33779523 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of humor
Number of subjects: 326
Study 33779523 — intervention group
Group type: COMPARATOR
Intervention: Absence of humor
Number of subjects: 326
Study 33779523 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of humor (Men)
Number of subjects: 326
Study 33779523 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of humor (Women)
Number of subjects: 326
Study 33779523 — intervention group
Group type: EXPERIMENTAL
Intervention: Bystander gender
Number of subjects: 326
Study 34383533 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Preventive Intervention (API)
Number of subjects: 891
Study 34383533 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource email
Number of subjects: 891
Study 34383533 — intervention group
Group type: EXPERIMENTAL
Intervention: Any API
Number of subjects: 891
Study 34383533 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 891
Study 33367869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 3000 IU daily
Number of subjects: 90
Study 33367869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 25,000 IU weekly
Number of subjects: 90
Study 33367869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 100,000 IU monthly
Number of subjects: 90
Study 33367869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU daily (maintenance course)
Number of subjects: 90
Study 33367869 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 32948747 — intervention group
Group type: EXPERIMENTAL
Intervention: discordant condition (safe and risky choices followed by angry and happy faces)
Number of subjects: 116
Study 32948747 — intervention group
Group type: EXPERIMENTAL
Intervention: concordant condition (safe and risky choices followed by happy and angry faces)
Number of subjects: 116
Study 35914913 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) and multidisciplinary intervention
Number of subjects: 0
Study 35914913 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 0
Study 34271882 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (LIFE4YOUth) consisting of recurring screening, text messages, and an interactive platform
Number of subjects: 0
Study 34271882 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group for 4 months
Number of subjects: 0
Study 34009912 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad training
Number of subjects: 101
Study 34009912 — intervention group
Group type: COMPARATOR
Intervention: Individual training
Number of subjects: 101
Study 34022947 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene device attached to a computer on wheels (COW)
Number of subjects: 39
Study 34022947 — intervention group
Group type: COMPARATOR
Intervention: Control (no hand hygiene device)
Number of subjects: 39
Study 35551495 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive diabetes risk score applied in primary care as an add-on to standard routine health checks.
Number of subjects: 315
Study 35551495 — intervention group
Group type: COMPARATOR
Intervention: Standard routine health checks without the diabetes risk score.
Number of subjects: 315
Study 34468743 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine rotavirus pentavalent vaccine (Rotasiil)
Number of subjects: 1729
Study 34468743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1729
Study 34344556 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion
Number of subjects: 27
Study 34344556 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-infiltration
Number of subjects: 27
Study 34344556 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study 32749877 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational-interviewing (MI) intervention over 24 weeks
Number of subjects: 0
Study 32749877 — intervention group
Group type: COMPARATOR
Intervention: Brief education
Number of subjects: 0
Study 36107632 — intervention group
Group type: EXPERIMENTAL
Intervention: FASTER-assisted ESD (FC group)
Number of subjects: 4
Study 36107632 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD (CF group)
Number of subjects: 4
Study 34971054 — intervention group
Group type: EXPERIMENTAL
Intervention: AAC Plus device
Number of subjects: 0
Study 35247524 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted gestational weight gain (GWG)
Number of subjects: 460
Study 35247524 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain (GWG)
Number of subjects: 460
Study 32162282 — intervention group
Group type: COMPARATOR
Intervention: Income Assistance
Number of subjects: 21
Study 32162282 — intervention group
Group type: COMPARATOR
Intervention: Federal Maternity Benefits based on minimum wage
Number of subjects: 21
Study 32162282 — intervention group
Group type: COMPARATOR
Intervention: $15/h wage
Number of subjects: 21
Study 36161538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ireland
Number of subjects: 25928
Study 36161538 — intervention group
Group type: COMPARATOR
Intervention: Denmark
Number of subjects: 25928
Study 33179374 — intervention group
Group type: EXPERIMENTAL
Intervention: Takotsubo syndrome (TTS) patients
Number of subjects: 32
Study 33179374 — intervention group
Group type: COMPARATOR
Intervention: Controls (age- and sex-matched)
Number of subjects: 32
Study 33179374 — intervention group
Group type: COMPARATOR
Intervention: Acute coronary syndrome (ACS) patients
Number of subjects: 32
Study 32331008 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole once-monthly 400 mg (AOM 400)
Number of subjects: 464
Study 36168186 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcarotid artery revascularization (TCAR)
Number of subjects: 851
Study 36168186 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger patients)
Number of subjects: 851
Study 34582438 — intervention group
Group type: EXPERIMENTAL
Intervention: Philani MObile Video Intervention for Exclusive breastfeeding (MOVIE) delivered by community health workers (CHWs) during home visits; replaced about 40% of CHWs' direct engagement time with participants.
Number of subjects: 1502
Study 34582438 — intervention group
Group type: COMPARATOR
Intervention: Standard of care counseling provided by mentor mothers in the control arm.
Number of subjects: 1502
Study 33065472 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NFB) training targeting sensorimotor α‐oscillations
Number of subjects: 45
Study 36221135 — intervention group
Group type: EXPERIMENTAL
Intervention: Early coagulopathy (defined by INR, platelets, APTT abnormalities)
Number of subjects: 227
Study 34029219 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) materials
Number of subjects: 33
Study 34029219 — intervention group
Group type: COMPARATOR
Intervention: Paper-based materials
Number of subjects: 33
Study 35569753 — intervention group
Group type: EXPERIMENTAL
Intervention: Heal-Me app + virtual group dietitian/exercise-specialist sessions
Number of subjects: 216
Study 35569753 — intervention group
Group type: EXPERIMENTAL
Intervention: Heal-Me app + virtual group and 1-to-1 dietitian/exercise-specialist sessions
Number of subjects: 216
Study 35569753 — intervention group
Group type: COMPARATOR
Intervention: Control: educational material
Number of subjects: 216
Study 35569753 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 216
Study 33350455 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-test
Number of subjects: 500
Study 33350455 — intervention group
Group type: COMPARATOR
Intervention: Standard care - cervical smear
Number of subjects: 500
Study 32563173 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 40
Study 32563173 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 40
Study 32563173 — intervention group
Group type: COMPARATOR
Intervention: Sham depletion
Number of subjects: 40
Study 33486536 — intervention group
Group type: EXPERIMENTAL
Intervention: en-bloc enucleation
Number of subjects: 600
Study 33486536 — intervention group
Group type: EXPERIMENTAL
Intervention: two-lobe enucleation
Number of subjects: 600
Study 33486536 — intervention group
Group type: EXPERIMENTAL
Intervention: three-lobe enucleation
Number of subjects: 600
Study 33486536 — intervention group
Group type: COMPARATOR
Intervention: en-bloc vs. two-lobe enucleation
Number of subjects: 600
Study 32418217 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball-end probe tip (0.6 mm diameter, 408 kPa)
Number of subjects: 20
Study 32418217 — intervention group
Group type: COMPARATOR
Intervention: Straight probe tip (0.45 mm diameter, 726 kPa)
Number of subjects: 20
Study 34364301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume walking HIIT (75 min/week)
Number of subjects: 30
Study 34364301 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT) (150 min/week)
Number of subjects: 30
Study 34291331 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (2 mg/kg/day of iron pidolate) from the third week of life to 6 months of post-conceptional age
Number of subjects: 66
Study 34291331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 33531017 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness script method intervention; taught clinical reasoning skills for three diseases during one clinical scenario
Number of subjects: 100
Study 33531017 — intervention group
Group type: COMPARATOR
Intervention: Control group; taught clinical presentation based on signs and symptoms of the same three diseases
Number of subjects: 100
Study 33531017 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness script method intervention
Number of subjects: 100
Study 33531017 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 33020411 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (Hyp, n = 10)
Number of subjects: 19
Study 33020411 — intervention group
Group type: COMPARATOR
Intervention: Intermittent normoxia (Norm, n = 9)
Number of subjects: 19
Study 33020411 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (Hyp)
Number of subjects: 19
Study 33020411 — intervention group
Group type: COMPARATOR
Intervention: Intermittent normoxia (Norm)
Number of subjects: 19
Study 36424705 — intervention group
Group type: EXPERIMENTAL
Intervention: Para-aortic lymphadenectomy (PALD)
Number of subjects: 728
Study 36424705 — intervention group
Group type: COMPARATOR
Intervention: No para-aortic lymphadenectomy (Control)
Number of subjects: 728
Study 33522667 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stitch (SS)
Number of subjects: 86
Study 33522667 — intervention group
Group type: COMPARATOR
Intervention: Long stitch (LS)
Number of subjects: 86
Study 34648118 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin plus cyclophosphamide followed by taxanes (ECT)
Number of subjects: 308
Study 34648118 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus taxanes (TP)
Number of subjects: 308
Study 34648118 — intervention group
Group type: COMPARATOR
Intervention: TP in SPARC (> 50%) subgroup
Number of subjects: 308
Study 34648118 — intervention group
Group type: COMPARATOR
Intervention: ECT in SPARC (≤ 50%), PD-L1 (-), PD-L1 (+), BRCA mutation or BRCA wild
Number of subjects: 308
Study 36175142 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower serum free testosterone
Number of subjects: 2741
Study 36175142 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher SHBG
Number of subjects: 2741
Study 36175142 — intervention group
Group type: COMPARATOR
Intervention: Cinacalcet treatment
Number of subjects: 2741
Study 36175142 — intervention group
Group type: EXPERIMENTAL
Intervention: Total testosterone
Number of subjects: 2741
Study 36175142 — intervention group
Group type: EXPERIMENTAL
Intervention: Free testosterone
Number of subjects: 2741
Study 36175142 — intervention group
Group type: EXPERIMENTAL
Intervention: SHBG
Number of subjects: 2741
Study 34241628 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with financial incentives
Number of subjects: 180
Study 34241628 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification without financial incentives
Number of subjects: 180
Study 34241628 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with social support
Number of subjects: 180
Study 34241628 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with social support and loss-framed financial incentive
Number of subjects: 180
Study 34241628 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 32143995 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic and resistance exercise program
Number of subjects: 48
Study 32143995 — intervention group
Group type: COMPARATOR
Intervention: Personal training, supervised group exercise, or home-based exercise (combined for primary analysis)
Number of subjects: 48
Study 36028192 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive panel management using the VA's HF dashboard
Number of subjects: 300
Study 36028192 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 34724895 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate follow-up requests
Number of subjects: 699
Study 34724895 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate follow-up requests
Number of subjects: 699
Study 34724895 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reviews during hospitalisation
Number of subjects: 699
Study 32232482 — intervention group
Group type: EXPERIMENTAL
Intervention: NCCN-IPI
Number of subjects: 2124
Study 32232482 — intervention group
Group type: COMPARATOR
Intervention: IPI
Number of subjects: 2124
Study 32232482 — intervention group
Group type: COMPARATOR
Intervention: R-IPI
Number of subjects: 2124
Study 34672898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cangrelor (intravenous P2Y12 receptor antagonist) as a bridging therapy
Number of subjects: 0
Study 34672898 — intervention group
Group type: COMPARATOR
Intervention: Standardized bridging protocol with cangrelor
Number of subjects: 0
Study 34955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot Reflexology
Number of subjects: 105
Study 34955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 105
Study 34955035 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 105
Study 32703680 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education
Number of subjects: 129
Study 32703680 — intervention group
Group type: COMPARATOR
Intervention: Daily activities (Control)
Number of subjects: 129
Study 35771740 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application intervention group
Number of subjects: 40
Study 35771740 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 33277680 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemopatch®
Number of subjects: 45
Study 35390113 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 600
Study 35390113 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 600
Study 36351419 — intervention group
Group type: EXPERIMENTAL
Intervention: Static posturography‐assisted biofeedback exercises (n = 20)
Number of subjects: 48
Study 36351419 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program (n = 21)
Number of subjects: 48
Study 33745137 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon‐occluded retrograde transvenous obliteration (BRTO)
Number of subjects: 0
Study 33745137 — intervention group
Group type: COMPARATOR
Intervention: Cyanoacrylate glue injection
Number of subjects: 0
Study 35615236 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS protocol with 8 interventions (increase cardiac output, normocapnia, increase mean arterial pressure, increase inspired oxygen, depth of anaesthesia, blood transfusion, correction of bypass cannula, change of surgical plan)
Number of subjects: 182
Study 35615236 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS protocol
Number of subjects: 182
Study 35615236 — intervention group
Group type: COMPARATOR
Intervention: Standard management without NIRS
Number of subjects: 182
Study 34400208 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 166
Study 34400208 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 166
Study 32436655 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital, continuous pump‐driven chest drainage system
Number of subjects: 120
Study 32436655 — intervention group
Group type: COMPARATOR
Intervention: Traditional wall‐suction system
Number of subjects: 120
Study 35618562 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol 270 mg I/ml
Number of subjects: 2
Study 35618562 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 2
Study 33397174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral TAP block
Number of subjects: 60
Study 33397174 — intervention group
Group type: COMPARATOR
Intervention: No TAP block (Control Group B)
Number of subjects: 60
Study 36484969 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 804
Study 36484969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 804
Study 33652438 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative Flicker Glass (AFG) - worn for 1 hour a day
Number of subjects: 40